Literature DB >> 1663052

No association between islet cell antibodies and Coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7-19 years.

W A Scherbaum1, W Hampl, P Muir, M Glück, J Seissler, H Egle, H Hauner, B O Boehm, E Heinze, J E Banatvala.   

Abstract

Viral antibodies were tested in a cohort of 44 islet-cell antibody-positive individuals age 7-19 years, and 44 of their islet cell antibody-negative age and sex-matched classmates selected from a population study of 4208 pupils who had been screened for islet cell antibodies. Anti-coxsackie B1-5 IgM responses were detected in 14 of 44 (32%) of the islet cell antibody-positive subjects and in 7 of 44 (16%) control subjects. This difference did not reach the level of statistical significance. None of the islet cell antibody-positive subjects had specific IgM antibodies to mumps, rubella, or cytomegalovirus. There was also no increase in the prevalence or the mean titres of anti-mumps-IgG or IgA and anti-cytomegalovirus-IgG in islet cell antibody-positive subjects compared to control subjects. These results do not suggest any association between islet cell antibodies, and possibly insulitis, with recent mumps, rubella or cytomegalovirus infection. Further studies are required to clarify the relationship between islet cell antibodies and coxsackie B virus infections.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663052     DOI: 10.1007/bf00408360

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

Review 1.  Viruses and the pathogenesis of diabetes mellitus.

Authors:  E J Rayfield; Y Seto
Journal:  Diabetes       Date:  1978-11       Impact factor: 9.461

2.  Islet cell antibodies in children with mumps infection.

Authors:  K Helmke; A Otten; W Willems
Journal:  Lancet       Date:  1980-07-26       Impact factor: 79.321

3.  Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies.

Authors:  E Bonifacio; A Lernmark; R L Dawkins
Journal:  J Immunol Methods       Date:  1988-01-21       Impact factor: 2.303

4.  A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes.

Authors:  W J Riley; N K Maclaren; J Krischer; R P Spillar; J H Silverstein; D A Schatz; S Schwartz; J Malone; S Shah; C Vadheim
Journal:  N Engl J Med       Date:  1990-10-25       Impact factor: 91.245

5.  The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children--no evidence of increased antibody frequency.

Authors:  T Tuvemo; G Dahlquist; G Frisk; L Blom; G Friman; M Landin-Olsson; H Diderholm
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

6.  Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia.

Authors:  J E Banatvala; J Bryant; G Schernthaner; M Borkenstein; E Schober; D Brown; L M De Silva; M A Menser; M Silink
Journal:  Lancet       Date:  1985-06-22       Impact factor: 79.321

7.  Mumps infection and insulin-dependent diabetes mellitus (IDDM).

Authors:  K P Ratzmann; J Strese; S Witt; H Berling; H Keilacker; D Michaelis
Journal:  Diabetes Care       Date:  1984 Mar-Apr       Impact factor: 19.112

8.  Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.

Authors:  J Karjalainen; M Knip; H Hyöty; P Leinikki; J Ilonen; M L Käär; H K Akerblom
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

9.  Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.

Authors:  M L King; A Shaikh; D Bidwell; A Voller; J E Banatvala
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

10.  High frequency of Coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity.

Authors:  G Frisk; J Fohlman; M Kobbah; U Ewald; T Tuvemo; H Diderholm; G Friman
Journal:  J Med Virol       Date:  1985-11       Impact factor: 2.327

View more
  3 in total

1.  Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function.

Authors:  J Seissler; B Hering; W Richter; M Glück; N Yassin; R G Bretzel; B O Boehm; K Federlin; W A Scherbaum
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

Review 2.  Diabetes mellitus due to viruses--some recent developments.

Authors:  T M Szopa; P A Titchener; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

3.  Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Authors:  J Seissler; J Amann; L Mauch; H Haubruck; S Wolfahrt; S Bieg; W Richter; R Holl; E Heinze; W Northemann
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.